ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children

R B Oriá1, P D Patrick, M O B Oriá

  • 1Departamento de Morfologia, Universidade Federal do Ceará.

Insights

Apolipoprotein E4 (APOE4) may protect children in urban shanty towns from developmental issues caused by severe diarrhea. This contrasts with its later-life risks, suggesting a complex role in early childhood development.

Area of Science:

  • Pediatric Health
  • Human Genetics
  • Developmental Biology

Background:

  • Severe diarrhea in early childhood negatively impacts physical and cognitive development.
  • Urban shanty towns present unique health challenges for children.
  • The apolipoprotein E (APOE) gene's role in early development is not fully understood.

Purpose of the Study:

  • To investigate the association between APOE genotype and developmental outcomes in children experiencing heavy diarrhea burdens.
  • To explore the potential protective role of APOE variants in early childhood under adverse conditions.

Main Methods:

  • Genotyping of APOE using Polymerase Chain Reaction (PCR) and restriction fragment length polymorphism.
  • Assessment of physical development (weight-for-height) and cognitive development.
  • Analysis of disease burden (diarrhea) in children from urban shanty towns in Brazil.

Main Results:

  • APOE4 was common (13.4%) and associated with better weight-for-height and cognitive development in children with severe diarrhea.
  • APOE2 frequency was higher in children with the heaviest diarrhea burdens.
  • These findings suggest APOE's role in cholesterol balance may be critical for development under stress.

Conclusions:

  • APOE4 may confer a survival advantage in early childhood by mitigating the effects of severe diarrhea.
  • ApoE-cholesterol pathways might be crucial for growth and cognitive development during periods of high stress, such as malnutrition and severe diarrhea.
  • Genetic variations in APOE could explain evolutionary survival advantages related to cholesterol regulation under early-life stress.

Related Concept Videos

Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...